NasdaqGS:INCYBiotechs
Incyte Expands Latin Reach As NIKTIMVO Push Meets Mixed Valuation Signals
Incyte (NasdaqGS: INCY) has expanded its partnership with Knight Therapeutics in Latin America, adding exclusive distribution rights for key therapies.
The companies are advancing the regulatory submission for NIKTIMVO in Brazil, targeting approval for use in chronic graft versus host disease and other indications.
This update reflects Incyte's wider efforts to grow its presence across Latin American markets beyond its existing portfolio.
For you as an investor, this move highlights how...